The DOI matches its Crossref record.
Prevention of Central Venous Catheter–Related Infections and Thrombotic Events in Immunocompromised Children by the Use of Vancomycin/Ciprofloxacin/Heparin Flush Solution: A Randomized, Multicenter, Double-Blind Trial
Abstract
PURPOSE: To determine whether an antibiotic flush solution containing vancomycin, heparin, and ciprofloxacin (VHC) can prevent the majority of line infections. PATIENTS AND METHODS: A prospective double-blind study was performed comparing VHC to vancomycin and heparin (VH) to heparin alone in 126 pediatric oncology patients. RESULTS: The 153 assessable lines resulted in 36,944 line days studied. There were 58 blood stream infections (43 Gram-positive, 14 Gram-negative, and one fungal). Forty were defined as line infections (31 heparin, three VH, six VHC). The time to develop a line infection was significantly increased using either antibiotic flush (VH, P = .011; VHC, P = .036). The rate of total line infections (VH, P = .004; VHC, P = .005), Gram-positive line infections (VH, P = .028; VHC, P = .022), and Gram-negative line infections (VH, P = .006; VHC, P = .003) was significantly reduced by either VH or VHC. Sixty-two (41%) of the lines developed 119 occlusion episodes (heparin, 3.99 per 1,000 line days; VHC, 1.75 per 1,000 line days; P = .0005). Neither antibiotic could be detected after flushing, and no adverse events were detected, including increased incidence of vancomycin-resistant Enterococcus colonization or disease. CONCLUSION: The use of either VH or VHC flush solution significantly decreased the complications associated with the use of tunneled central venous lines in immunocompromised children and would save significant health care resources.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Guidelines for the Prevention of Intravascular Catheter-related Infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,699
Preventing Complications of Central Venous Catheterization
McGee, D. C., & Gould, M. K. (2003) · New England Journal of Medicine · doi:10.1056/nejmra011883 · Cited by 2,290
Guidelines for the prevention of intravascular catheter-related infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · American Journal of Infection Control · doi:10.1016/j.ajic.2011.01.003 · Cited by 1,066
Guidelines for the Prevention of Intravascular Catheter–Related Infections
O’Grady, N. P., Alexander, M., Dellinger, E. P., Gerberding, J. L., Heard, S. O., Maki, D. G., Masur, H., McCormick, R. D., Mermel, L. A., Pearson, M. L., et al. (2002) · Infection Control and Hospital Epidemiology · doi:10.1086/502007 · Cited by 847
Guidelines for the Prevention of Intravascular Catheter-Related Infections
O’Grady, N. P., Alexander, M., Dellinger, E. P., Gerberding, J. L., Heard, S. O., Maki, D. G., Masur, H., McCormick, R. D., Mermel, L. A., Pearson, M. L., et al. (2002) · Pediatrics · doi:10.1542/peds.110.5.e51 · Cited by 738
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir138 · Cited by 560
Marschall, J., Mermel, L. A., Fakih, M., Hadaway, L., Kallen, A., O’Grady, N. P., Pettis, A. M., Rupp, M. E., Sandora, T., Maragakis, L. L., et al. (2014) · Infection Control & Hospital Epidemiology · doi:10.1086/676533 · Cited by 550
Intravascular catheter-related infections: advances in diagnosis, prevention, and management
Raad, I., Hanna, H., & Maki, D. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70235-9 · Cited by 525
Slobbe, L., Doorduijn, J. K., Lugtenburg, P. J., el Barzouhi, A., Boersma, E., van Leeuwen, W. B., & Rijnders, B. J. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010840 · Cited by 490
Buetti, N., Marschall, J., Drees, M., Fakih, M. G., Hadaway, L., Maragakis, L. L., Monsees, E., Novosad, S., O’Grady, N. P., Rupp, M. E., et al. (2022) · Infection Control & Hospital Epidemiology · doi:10.1017/ice.2022.87 · Cited by 475
Strategies to Prevent Central Line–Associated Bloodstream Infections in Acute Care Hospitals
Marschall, J., Mermel, L. A., Classen, D., Arias, K. M., Podgorny, K., Anderson, D. J., Burstin, H., Calfee, D. P., Coffin, S. E., Dubberke, E. R., et al. (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591059 · Cited by 458
Guidelines for the Prevention of Intravascular Catheter–Related Infections
O'Grady, N. P., Alexander, M., Dellinger, E. P., Gerberding, J. L., Heard, S. O., Maki, D. G., Masur, H., McCormick, R. D., Mermel, L. A., Pearson, M. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/344188 · Cited by 440
Clinical Microbiology of Bacterial and Fungal Sepsis in Very-Low-Birth-Weight Infants
Kaufman, D., & Fairchild, K. D. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.3.638-680.2004 · Cited by 435
Guidelines for the prevention of intravascular catheter-related infections
O'Grady, N. P., Alexander, M., Dellinger, E. P., Gerberding, J. L., Heard, S. O., Maki, D. G., Masur, H., McCormick, R. D., Mermel, L. A., Pearson, M. L., et al. (2002) · American Journal of Infection Control · doi:10.1067/mic.2002.129427 · Cited by 415
Coagulase-Negative Staphylococcal Infections
Rogers, K. L., Fey, P. D., & Rupp, M. E. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2008.10.001 · Cited by 401
Schiffer, C. A., Mangu, P. B., Wade, J. C., Camp-Sorrell, D., Cope, D. G., El-Rayes, B. F., Gorman, M., Ligibel, J., Mansfield, P., & Levine, M. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.5733 · Cited by 368
Guidelines for the Prevention of Intravascular Catheter–Related Infections
O'Grady, N. P., Alexander, M., Dellinger, E. P., Gerberding, J. L., Heard, S. O., Maki, D. G., Masur, H., McCormick, R. D., Mermel, L. A., Pearson, M. L., et al. (2002) · Infection Control & Hospital Epidemiology · doi:10.1017/s0195941700080577 · Cited by 319
Effects of Bacteriocins on Methicillin-Resistant Staphylococcus aureus Biofilm
Okuda, K.-I., Zendo, T., Sugimoto, S., Iwase, T., Tajima, A., Yamada, S., Sonomoto, K., & Mizunoe, Y. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00888-13 · Cited by 305
Management of venous port systems in oncology: a review of current evidence
Vescia, S., Baumgärtner, A. K., Jacobs, V. R., Kiechle-Bahat, M., Rody, A., Loibl, S., & Harbeck, N. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm272 · Cited by 264
SAFDAR, N., KLUGER, D. M., & MAKI, D. G. (2002) · Medicine · doi:10.1097/00005792-200211000-00007 · Cited by 261
Metadata
- Authors
- Henrickson, K. J., Axtell, R. A., Hoover, S. M., Kuhn, S. M., Pritchett, J., Kehl, S. C., & Klein, J. P.
- Venue
- Journal of Clinical Oncology
- Published
- 2000-03-13
- Volume
- 18
- Issue
- 6
- Pages
- 1269-1278
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2214339244
- Cited by
- 222
- References
- 0
- FWCI
- 21.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.